Research
I am interested in understanding how genetic and cellular abnormalities drive human disease to design targeted molecular therapies.
My research takes advantage of patient-derived iPSCs and multi-omics to dissect LMNA-related cardiomyopathy, cardiac fibrosis, and nuclear mechanobiology. Much of my work focuses on antisense oligonucleotides (ASOs), delivery systems, chemical technology, nanotechnology, high-throughput small-molecule screening, and computational approaches to develop targeted therapies for currently untreatable human diseases.
Previously, my research spans ASO optimization for rare musculoskeletal diseases and public health genetics, driven by a commitment to open science and accessible molecular medicine.
Human disease modelling and next-gen drug discovery for human diseases
Elucidating the molecular underpinnings of cardiovascular and musculoskeletal diseases
Genetic epidemiology of diseases in low- and lower-middle-income countries, e.g., Bangladesh
I believe in open science, collaboration, and knowledge sharing. I welcome questions, feedback, and opportunities to collaborate in genetic medicine, cardiovascular research, therapeutic development, disease modelling, and public health.
Please feel free to contact me to discuss my research or explore potential collaborations.